文献速递类风湿关节炎

雷公藤红素对关节炎大鼠骨结构与力学的影响

Effect of celastrol on bone structure and mechanics in arthritic rats.
PubMed 文献 · RMD Open · 2017-09-14

该研究在雌性Wistar佐剂诱导关节炎大鼠中腹腔注射雷公藤红素1 µg/g/天,22天后评估骨重塑标志物、三点弯曲试验、micro-CT、纳米压痕及傅里叶变换红外光谱。结果显示雷公藤红素保护关节结构、减少破骨细胞与成骨细胞数量、降低血清骨与软骨降解标志物,并防止骨丢失与骨微结构退化,同时保留骨纳米特性与最大载荷。

要点

  • 雷公藤红素减少关节炎关节内破骨细胞与成骨细胞数量并保护关节结构
  • 雷公藤红素降低TRAP5b、P1NP及CTX-II血清水平,提示抑制骨吸收与软骨降解
  • 雷公藤红素改善骨微结构与力学性能,最大载荷与屈服位移增加

核心结论

  • 雷公藤红素可减少骨吸收与软骨降解,并保留关节炎大鼠的骨结构特性。

研究设计与样本

  • 在雌性Wistar佐剂诱导关节炎大鼠中腹腔注射雷公藤红素1 µg/g/天,病程22天后采集血、股骨、胫骨与足爪样本进行分析。

主要发现

  • 雷公藤红素保护关节结构并减少关节炎关节内破骨细胞与成骨细胞数量。
  • 雷公藤红素降低血清TRAP5b、P1NP及CTX-II水平。
  • 雷公藤红素防止骨丢失与骨微结构退化,并保留骨纳米特性与矿物含量。
  • 雷公藤红素治疗动物骨脆性降低,表现为最大载荷与屈服位移增加。

临床怎么用

  • 结果提示雷公藤红素可能同时靶向骨吸收与软骨降解,为RA骨保护提供候选药物,但尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is characterised by chronic inflammation leading to articular bone and cartilage damage. Despite recent progress in RA management, adverse effects, lack of efficacy and economic barriers to treatment access still limit therapeutic success. Therefore, safer and less expensive treatments that control inflammation and bone resorption are needed. We have previously shown that celastrol is a candidate for RA treatment. We have observed that it inhibits both interleukin (IL)-1β and tumor necrosis factor (TNF) in vitro, and that it has anti-inflammatory properties and ability to decrease synovial CD68+ macrophages in vivo. Herein our goal was to evaluate the effect of celastrol in local and systemic bone loss. METHODS: Celastrol was administrated intraperitoneally at a dose of 1 µg/g/day to female Wistar adjuvant-induced arthritic rats. Rats were sacrificed after 22 days of disease progression, and blood, femurs, tibiae and paw samples were collected for bone remodelling markers quantification, 3-point bending test, micro-CT analysis, nanoindentation and Fourier transform infrared spectroscopy measurements, and immunohistochemical evaluation. RESULTS: We have observed that celastrol preserved articular structures and decreased the number of osteoclasts and osteoblasts present in arthritic joints. Moreover, celastrol reduced tartrate-resistant acid phosphatase 5b, procollagen type 1 amino-terminal propeptide and C terminal crosslinked telopeptide of type II collagen serum levels. Importantly, celastrol prevented bone loss and bone microarchitecture degradation. Celastrol also preserved bone nanoproperties and mineral content. Additionally, animals treated with celastrol had less fragile bones, as depicted by an increase in maximum load and yield displacement. CONCLUSIONS: These results suggest that celastrol reduces both bone resorption and cartilage degradation, and preserves bone structural properties.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Cascão R, Vidal B, Jalmari Finnilä MA, et al. Effect of celastrol on bone structure and mechanics in arthritic rats. RMD Open. 2017. PMID: 28955491. doi:10.1136/rmdopen-2017-000438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。